retatrutide clinical trial effects Triple hormone receptor agonist for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a ESC 2024: Retatrutide improves lipid

Pharmacologic approaches to glycemic treatment: standards of care in diabetes-2025

This leads to the formation of regenerative hepatic nodules encased in dense fibrous tissue, containing significantly higher levels of extracellular matrix proteins, particularly collagen types I, III, and IV, which hinder portal blood flow and elevate portal pressure, ultimately culminating in clinically significant portal hypertension in later disease stages ( In this comprehensive and evidence-driven review, the objective is to scrutinize the repercussions, diagnosis, and management of these often overlooked yet prevalent and challenging-to-treat symptoms encountered in cirrhosis (Figure 1)

Garcia-Perez L-E, Maldonado JM, Ranta KT, Raha S

Designed for fitness enthusiasts, it is suitable for both men and women aiming to optimise endurance and body composition